Non-Current Liabilities

Debt Instrument Face Amount

Amgen Debt Instrument Face Amount decreased by 83.3% to $4.00B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ2 2017
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase indicates higher leverage, while a decrease indicates debt repayment or deleveraging.

Detailed definition

This represents the total principal or par value of debt instruments issued by the company, excluding premiums or discou...

Peer comparison

Standard metric for assessing total corporate indebtedness across all industries.

Metric ID: debt_instrument_face_amount

Historical Data

4 periods
 Q1 '23Q2 '23Q3 '23Q1 '26
Value$24.00B$24.00B$24.00B$4.00B
QoQ Change—+0.0%+0.0%-83.3%
Range$4.00B – $24.00B

Debt Instrument Face Amount at Other Companies

LPL Financial Holdings logo
LPL Financial HoldingsLPLAView metric
U.S. Bancorp logo
U.S. BancorpUSBView metric
Bank of America logo
Bank of AmericaBACView metric
AT&T logo
AT&TTView metric
LTR
LTRLTRView metric
VICI Properties Inc. logo
VICI Properties Inc.VICIView metric

Frequently Asked Questions

What is Amgen's debt instrument face amount?
Amgen (AMGN) reported debt instrument face amount of $4.00B in Q1 2026.
What does debt instrument face amount mean?
The total principal amount of debt owed by the company.